Therapeutic Potential of the Gut Microbiota in the Management of Sepsis

scientific article published on 24 March 2020

Therapeutic Potential of the Gut Microbiota in the Management of Sepsis is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1186/S13054-020-2780-3
P932PMC publication ID7092471
P698PubMed publication ID32204720

P50authorMatteo BassettiQ88607142
P2093author name stringAlessandra Bandera
Andrea Gori
P2860cites workResurrecting the intestinal microbiota to combat antibiotic-resistant pathogensQ28075653
The Gut as the Motor of Multiple Organ Dysfunction in Critical IllnessQ28274385
Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndromeQ28821251
Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trialQ34268939
Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantationQ34311369
Microbiota-mediated colonization resistance against intestinal pathogensQ34324937
Altered gut flora are associated with septic complications and death in critically ill patients with systemic inflammatory response syndrome.Q34691263
Fecal microbiota transplantation: facts and controversiesQ35044957
Successful treatment of severe sepsis and diarrhea after vagotomy utilizing fecal microbiota transplantation: a case reportQ35136477
Hospitalization Type and Subsequent Severe SepsisQ36128633
Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection.Q36198872
Collapse of the Microbiome, Emergence of the Pathobiome, and the Immunopathology of SepsisQ36252387
Antibiotic regimens and intestinal colonization with antibiotic-resistant gram-negative bacilliQ36559369
Metagenomic Analysis Reveals Dynamic Changes of Whole Gut Microbiota in the Acute Phase of Intensive Care Unit PatientsQ36922472
Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysisQ37189190
Effectiveness of Probiotic, Prebiotic, and Synbiotic Therapies in Reducing Postoperative Complications: A Systematic Review and Network Meta-analysis.Q39285999
Probiotic pre-administration reduces mortality in a mouse model of cecal ligation and puncture-induced sepsisQ39429041
Dysbiosis Across Multiple Body Sites in Critically Ill Adult Surgical PatientsQ39563579
The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens.Q40063718
The Intestinal Microbiome in Infectious Diseases: The Clinical Relevance of a Rapidly Emerging Field.Q40075191
A randomized synbiotic trial to prevent sepsis among infants in rural IndiaQ40081393
Comparative effectiveness of faecal microbiota transplant by route of administrationQ40214260
Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trialQ40886498
Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients.Q41194710
Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trialQ42240129
Bacterial Dissemination to the Brain in SepsisQ46242978
Risk Factors for Carbapenem-resistant Klebsiella pneumoniae Infection and Mortality of Klebsiella pneumoniae InfectionQ47260522
Effect of Oral Capsule- vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical TrialQ47548289
Risk of Subsequent Sepsis within 90 Days of a Previous Hospital Stay by Type of Antibiotic ExposureQ47599691
The microbiome of the critically ill patientQ47652525
Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: a randomized controlled trialQ59128544
Altered gut microbiota after traumatic splenectomy is associated with endotoxemiaQ59798581
Lactobacillus rhamnosus GG treatment improves intestinal permeability and modulates microbiota dysbiosis in an experimental model of sepsisQ61804559
Challenge to the Intestinal Mucosa During SepsisQ64078780
Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trialQ82970230
Fecal microbiota transplantation: donor relation, fresh or frozen, delivery methods, cost-effectivenessQ90833515
A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trialQ90923666
The gut microbiome alters immunophenotype and survival from sepsisQ91887634
Western diet regulates immune status and the response to LPS-driven sepsis independent of diet-associated microbiomeQ91943172
Mice Fed an Obesogenic Western Diet, Administered Antibiotics, and Subjected to a Sterile Surgical Procedure Develop Lethal Septicemia with Multidrug-Resistant PathobiontsQ92295478
Gut Microbiota Modulation for Multidrug-Resistant Organism Decolonization: Present and Future PerspectivesQ92556893
Keeping Candida commensal: how lactobacilli antagonize pathogenicity of Candida albicans in an in vitro gut modelQ92623495
Evaluating probiotics for the prevention of ventilator-associated pneumonia: a randomised placebo-controlled multicentre trial protocol and statistical analysis plan for PROSPECTQ92946318
Faecal microbiota transplantation for eradicating carriage of multidrug-resistant organisms: a systematic reviewQ93100771
P433issue1
P921main subjectsepsisQ183134
P304page(s)105
P577publication date2020-03-24
P1433published inCritical CareQ5186602
P1476titleTherapeutic Potential of the Gut Microbiota in the Management of Sepsis
P478volume24

Search more.